ETXPF   $0.19  -5.00% Market Closed

e-Therapeutics PLC
Total Cash
totalCashPerShare
EBITDA
Total Debt
quickRatio
currentRatio
Total Revenue
debtToEquity
Revenue/Share 0.001
ROA
ROE
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue
forwardPE
floatShares
sharesOutstanding 584.33M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.59%
heldPercentInstitutions 0.27%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.038
Price To Book help_outline 3.42
earningsQuarterlyGrowth
netIncomeToCommon
trailingEps -0.02%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 7
lastUpdated Nov. 7, 2024, 5:17 a.m.